Management of cardiovascular disorder in Zimbabwe: 1989-1992

C Marks1, W Mahalu, S Kuskov

  • 1Department of Cardiothoracic Surgery, Parirenyatwa Hospital, Harare, Zimbabwe.

Insights

Establishing a cardiothoracic unit in a developing country highlighted the need for open-heart surgery due to high rates of rheumatic valvular and congenital heart disease. Successful implementation requires addressing economic, logistic, and educational challenges.

Area of Science:

  • Cardiothoracic Surgery
  • Global Health
  • Developing Economies

Background:

  • High incidence of rheumatic valvular disease in Zimbabwe.
  • Significant rates of congenital cardiac disorders in the Zimbabwean population.
  • Clinical necessity for advanced cardiac surgical services in underserved regions.

Purpose of the Study:

  • To assess the feasibility and challenges of establishing a cardiothoracic unit with open-heart surgical capabilities in a third-world setting.
  • To highlight the specific cardiac conditions prevalent in the Zimbabwean population requiring surgical intervention.
  • To outline the essential components for the sustainable development of such a unit.

Main Methods:

  • Qualitative analysis of challenges in establishing a specialized medical unit in a resource-limited environment.
  • Review of epidemiological data on valvular and congenital heart disease in the target population.
  • Framework development for unit maturation focusing on patient care, education, and research.

Main Results:

  • Significant economic and logistical hurdles impede the establishment of advanced surgical facilities in developing nations.
  • Rheumatic valvular disease and congenital heart disorders are highly prevalent, creating a substantial demand for cardiothoracic services.
  • A successful unit requires continuous attention to patient needs, staff education, and research.

Conclusions:

  • Establishing a cardiothoracic unit in a developing country is clinically vital but faces considerable economic and logistical obstacles.
  • Addressing the high burden of valvular and congenital heart disease necessitates specialized surgical care.
  • Sustainable unit development depends on a holistic approach encompassing patient-centered care, ongoing training, and research.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...